4.36
price down icon4.39%   -0.20
after-market After Hours: 4.39 0.03 +0.69%
loading
Precigen Inc stock is traded at $4.36, with a volume of 6.21M. It is down -4.39% in the last 24 hours and up +125.91% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$4.56
Open:
$4.63
24h Volume:
6.21M
Relative Volume:
0.86
Market Cap:
$1.30B
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-11.18
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
-3.33%
1M Performance:
+125.91%
6M Performance:
+125.91%
1Y Performance:
+354.64%
1-Day Range:
Value
$4.32
$4.64
1-Week Range:
Value
$4.32
$5.225
52-Week Range:
Value
$0.6513
$5.225

Precigen Inc Stock (PGEN) Company Profile

Name
Name
Precigen Inc
Name
Phone
301-556-9900
Name
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Employee
25
Name
Twitter
@precigen
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PGEN
Precigen Inc
4.36 1.36B 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-15-25 Upgrade JP Morgan Underweight → Neutral
Mar-22-24 Downgrade JP Morgan Neutral → Underweight
May-23-23 Initiated JP Morgan Neutral
Nov-18-22 Initiated Cantor Fitzgerald Overweight
Feb-25-21 Initiated Stifel Buy
Feb-22-21 Initiated Wells Fargo Overweight
Feb-18-21 Initiated B. Riley Securities Buy
May-08-20 Initiated H.C. Wainwright Buy
View All

Precigen Inc Stock (PGEN) Latest News

pulisher
02:29 AM

Visual trend scoring systems applied to Precigen Inc.2025 Trading Recap & Consistent Growth Stock Picks - Newser

02:29 AM
pulisher
01:19 AM

PGEN: JMP Securities Raises Price Target, Maintains Rating | PGE - GuruFocus

01:19 AM
pulisher
09:15 AM

Should you wait for a breakout in Precigen Inc.July 2025 Intraday Action & Long-Term Safe Investment Plans - Newser

09:15 AM
pulisher
05:13 AM

Is Precigen Inc. a top pick in the sectorRecession Risk & AI Powered Market Entry Ideas - خودرو بانک

05:13 AM
pulisher
04:46 AM

Is Precigen Inc. stock good for income investorsJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک

04:46 AM
pulisher
02:45 AM

What’s the profit margin of Precigen Inc.2025 Buyback Activity & Consistent Income Trade Ideas - خودرو بانک

02:45 AM
pulisher
02:33 AM

Is Precigen Inc. a play on infrastructure spending2025 EndofYear Setup & Risk Managed Investment Entry Signals - خودرو بانک

02:33 AM
pulisher
Sep 05, 2025

Nancy Agee Increases Stake in Precigen Inc with Recent Purchase - GuruFocus

Sep 05, 2025
pulisher
Sep 05, 2025

Agee Nancy H, Precigen director, buys $69,000 in shares - Investing.com

Sep 05, 2025
pulisher
Sep 05, 2025

Live market analysis of Precigen Inc.Analyst Downgrade & Entry and Exit Point Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Candlestick signals on Precigen Inc. stock todayShort Setup & Smart Swing Trading Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Precigen Inc. stock risky to hold nowOptions Play & Weekly Setup with ROI Potential - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Is Precigen Inc. stock bottoming outJuly 2025 Macro Moves & Reliable Price Breakout Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Will Precigen Inc. outperform the marketJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Is a relief rally coming for Precigen Inc. holdersBear Alert & Community Trade Idea Sharing - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Reversal indicators forming on Precigen Inc. stockIPO Watch & Reliable Breakout Forecasts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Precigen, Inc. shares rise 1.05% premarket after securing a $125 million credit facility. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Custom watchlist performance reports with Precigen Inc.July 2025 Review & Technical Pattern Alert System - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to recover losses in Precigen Inc. stockJuly 2025 Snapshot & Capital Efficient Trading Techniques - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Using data filters to optimize entry into Precigen Inc.July 2025 Weekly Recap & High Accuracy Investment Signals - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Key metrics from Precigen Inc.’s quarterly dataTrade Exit Report & Safe Capital Growth Plans - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Precigen Secures $125 Mln Credit Facility From Pharmakon To Advance PAPZIMEOS Commercialization - Nasdaq

Sep 03, 2025
pulisher
Sep 03, 2025

Germantown's Precigen secures $125M loan to take first drug to market - The Business Journals

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen, Inc. announced that it expects to receive $125 million in funding - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen announces up to $125M non-dilutive financing - MSN

Sep 03, 2025
pulisher
Sep 03, 2025

What earnings revisions data tells us about Precigen Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Sector Update: Health Care - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

BioPharma Credit to Invest $62.5 Million in US-based Precigen - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen Signs Up to $125 Million Credit Facility Deal With Pharmakon Advisors - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

News impact scoring models applied to Precigen Inc.Options Play & Risk Controlled Stock Pick Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen’s Non-Dilutive $125M Financing: A Strategic Inflection Point for Commercialization and Shareholder Value - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen secures $100 million in non-dilutive financing - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen Secures $125M Loan for PAPZIMEOS Expansion - TipRanks

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen secures up to $125 million in senior secured loan financing - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen secures up to $125 million in senior secured loan financing By Investing.com - Investing.com Australia

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen secures $100 million in non-dilutive financing By Investing.com - Investing.com UK

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen Secures Up to $125 Million Non-Dilutive Financing for Commercialization of PAPZIMEOS - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

$125M Non-Dilutive Deal: Precigen Secures Major Funding for Revolutionary HPV Immunotherapy Launch - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

What makes Precigen Inc. stock price move sharplyJuly 2025 Review & Weekly High Potential Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Precigen Inc. stock trendline breakdownJuly 2025 Reactions & Verified Swing Trading Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Building trade automation scripts for Precigen Inc.Dollar Strength & Verified Chart Pattern Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Precigen upgraded to Neutral from Underweight at JPMorgan - MSN

Sep 02, 2025
pulisher
Sep 02, 2025

How high can Precigen Inc. stock goJuly 2025 Volume & Risk Managed Investment Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Precigen, Inc. shares rise 1.68% after-hours following a special call with CEO and CCO. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Tennant Company shares fall 1.46% intraday after Precigen, Inc. special call featuring CEO and CCO. - AInvest

Sep 02, 2025

Precigen Inc Stock (PGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Cap:     |  Volume (24h):